Katherine Linder, Chaitanya Iragavarapu, & Delong Liu. (2017). SETBP1 mutations as a biomarker for myelodysplasia /myeloproliferative neoplasm overlap syndrome. BMC.
Chicago Style (17th ed.) CitationKatherine Linder, Chaitanya Iragavarapu, and Delong Liu. SETBP1 Mutations as a Biomarker for Myelodysplasia /myeloproliferative Neoplasm Overlap Syndrome. BMC, 2017.
MLA (9th ed.) CitationKatherine Linder, et al. SETBP1 Mutations as a Biomarker for Myelodysplasia /myeloproliferative Neoplasm Overlap Syndrome. BMC, 2017.
Warning: These citations may not always be 100% accurate.